We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Green was alleged to have acquired shares in Southwest for a nominal sum in exchange for a guaranteed “dividend” worth about $5,000 per month, as long as she referred a certain amount of urine drug screens. Read More
The most frequent defendants included Teva Pharmaceuticals and Teva Pharmaceutical Industries at 73 and 45 cases, respectively, Mylan at 46 cases and Apotex at 44 cases. Read More
In cases where the FDA must redact information from the Clinical Study Report, the agency will handle the process in-house rather than through a third party. Read More